loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 6267 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Atabay

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Atabay (1)

    filter

    01 ACETAMINOPHEN (1)

    filter

    01 Turkey (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    ATABAY KIMYA SANAYI VE TICARET AS

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Turkey
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ACETAMINOPHEN

    PDF Supplier PDF
    URL Supplier Web Content
    6267
    Active
    1986-04-14
    Complete
    2012-12-26
    2012-11-29
    II
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Drug Master Files (DMF) for 6267 of Atabay Kimya Sanayi Ve Ticaret As

    Looking for Drug Master Files (DMF) for 6267 of Atabay Kimya Sanayi Ve Ticaret As 1

    20

    Atabay Kimya Sanayi Ve Ticaret As, based in Turkey, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ACETAMINOPHEN, with a corresponding US DMF Number 6267.

    Remarkably, this DMF maintains an Active status since its submission on April 14, 1986, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of December 26, 2012, and payment made on November 29, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY